Biotech


  • Image attribution tooltip
    Space Frontiers via Getty Images
    Profile

    Vaxxinity looks to pioneer the next revolution in pharma

    With a one-of-a-kind platform and novel candidates for major indications, Vaxxinity wants to disrupt the industry’s paradigm of success. 

    By Jan. 14, 2022
  • Image attribution tooltip
    Spencer Platt via Getty Images
    Opinion

    Pharma execs reveal the industry's most pressing issues

    Several market factors — including COVID — are driving changes and trends in the industry.

    By Taren Grom • Jan. 14, 2022
  • Image attribution tooltip
    Jack Taylor via Getty Images

    Pharma M&A stagnated in 2021 — here's what could help it rebound

    There are plenty of reasons pharma could get its M&A groove back in 2022.

    By Jan. 13, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice

    Welcome to the new PharmaVoice

    A similar mission, a new format, and our plans for PharmaVoice's next chapter.

    By Davide Savenije • Jan. 13, 2022
  • Image attribution tooltip
    Permission granted by Copyright: <a href='https://www.123rf.com/profile_ileezhun'>ileezhun</a>

    Biote CEO breaks down barriers in women's health

    Women’s health is coming into sharper focus in 2022, but getting funding is still difficult.

    By Jan. 11, 2022
  • Image attribution tooltip
    [photo]. Retrieved from Ovid Therapeutics.
    Q&A

    Ovid's CEO shares his vision for rare disease developments

    Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.

    By Kim Ribbink • Jan. 10, 2022
  • Image attribution tooltip
    Justin Sullivan/ via Getty Images
    Q&A

    How the executive VP of HR at Incyte is tackling pharma's hiring woes

    In an industry undergoing rapid growth, the increasing job opening rates and limited talent pool are taking on a new level of importance.

    By Jan. 10, 2022
  • Image attribution tooltip
    Justin Sullivan via Getty Images

    Australian firefighters raise funds for ALS research

    Funding for rare disease clinical trials can be a challenge, but in Australia, firefighters gear up to raise money for ALS. 

    By Kim Ribbink • Jan. 5, 2022
  • Image attribution tooltip
    [photo]. Retrieved from Google image.

    Rare disease innovation in 2022

    More companies are targeting gene therapies for rare disease treatments.

    By Kim Ribbink • Jan. 5, 2022
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Profile

    PharmaVoice 100 Who's on the List – By Category

    Who’s on the List — 2021 Indexed by Category Commanders & Chiefs Dr. Sam Agresta Foghorn Therapeutics Alisha Alaimo Biogen Shideh Bina Insigniam Dr. Norbert Bischofberger Kronos Bio Dr. James Kyle Bryan IQVIA Biotech Victor Bultó Novartis Pharmaceuticals Dr. Tony ...

    By PharmaVoice Team • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Profile

    Entrepreneurs

    These visionary leaders recognized an opportunity to fill an industry need and are successfully leading their companies to new heights. Do you have CLAS? (Culturally and Linguistically Appropriate Strategies) Igniting change by… Having courageous conversations about race, ethnicity...

    By PharmaVoice Team • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Profile

    Change Agents

    These forward-thinking individuals are disrupting the status quo and setting the strategic direction for their companies to capitalize on the opportunities that will shape the future of the healthcare ecosystem. Put people first, the rest will follow Sparking innovation by… collabor...

    By PharmaVoice Team • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    2021 Red Jacket Honorees

    Inspiring leaders for today and tomorrow Since launching the Red Jacket Award in 2014, PharmaVOICE has recognized 40 inspiring, innovative, collaborative, and transformative individuals who epitomize leadership for today and tomorrow. One of the criteria for being named a Red Jacket — our version...

    By PharmaVoice Team • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Profile

    Red Jacket Ahsan Awan

    A man of many talents Sparking innovation by… creating a world that works for everyone Ahsan A. Awan Title: VP of Clinical Development Company: Genlantis Diagnostics Education: J.D., University of Oregon School of Law; M.S.Pharm., Pharmacy, Pharmacoeconomics, University of Florid...

    By Ahsan Awan • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Profile

    Red Jacket Jack Barrette

    Giving a voice to patient advocates Sparking innovation by… powering human connections for a healthier world Jack Barrette Title: Chief Innovation Officer, Health Union (formerly Founder & CEO of WEGO Health) Company: Health Union Education: B.A., English Industry Awards: Ph...

    By Jack Barrette • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Profile

    Red Jacket Olivier Chateau

    Redefining social health Blazing new trails by… innovating online communities Olivier Chateau Title: Co-Founder and CEO Company: Health Union Industry Awards: PharmaVOICE 100, 2018, 2009; EY Entrepreneur of the Year Award, 2020 Company Awards: Inc.’s Best Workplaces; Forbe...

    By Olivier Chateau • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Profile

    Red Jacket Laurie Cooke

    A leader of leaders Blazing new trails by… advancing gender parity and equity Laurie Cooke, RPh Title: President and CEO Company: Healthcare Businesswomen’s Association Education: PG Dip, Software Engineering Management, University of Luton; Advanced Degree, Pharmacy, Unive...

    By Laurie Cooke • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Profile

    Red Jacket Debbie Hart

    The great biotech convener Sparking innovation by… convening companies across the N.J. life-sciences ecosystem Debbie Hart Title: President and CEO Company: BioNJ Education: M.S., cum laude, S. I. Newhouse School at Syracuse University; B.A., magnum cum laude, Trenton State Colle...

    By Debbie Hart • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Profile

    Red Jacket Dr. Antony Loebel

    Bringing innovation to patients with serious CNS conditions Sparking innovation by… Transforming the discovery and development of central nervous system treatments Antony Loebel, M.D. Title: President and CEO Company: Sunovion Pharmaceuticals Inc. Education: B.A., University of W...

    By Antony Loebel • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Profile

    Red Jacket Steven Michaelson

    Making magic happen Sparking innovation by… creating opportunities for talent to flourish Steven Michaelson Title: Founder and CEO Company: Calcium Education: BFA, Pratt Institute Industry Awards: 2021, The Pinnacle Award; Winner, MM&M, 2019 Industry Person of the Year; MedA...

    By Steven Michaelson • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Personalized Medicine: A Work in Progress

    Advances in big-data analytics are increasingly being employed to extract targeted information with the potential to drive life-sciences research and clinical practice closer to the goal of personalized and precision medicine. The advent of big data is transforming both life-sciences research and...

    By PharmaVoice Team • June 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    2021 HBA Rising Stars and Luminaries

    More than 155 executives representing a wide range of companies in the life-sciences industry, have been selected by their organizations as exemplary leaders and role models. In this annual special section, we are honored to shine a light on their accomplishments in leading through unprecedented ...

    By PharmaVoice Team • May 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    The Changing Face of Patient Recruitment

    As the pandemic forced some clinical trial sites to shut down and numerous ongoing studies to pause, patient recruitment also slowed to a crawl, piling one more challenge onto an area that traditionally is fraught with difficulty. According to the Center for Information & Study on Clinical Re...

    By PharmaVoice Team • May 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Upfront

    Astellas Oncology Fifth Annual C3 Prize Winners Astellas Oncology has named the winners of its 5th Annual C3 Prize(Changing Cancer Care), a global challenge that sparks cancer care innovations beyond medicine to advance ideas that make a big impact in the cancer community. The program awards up t...

    By PharmaVoice Team • April 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    HealthTech

    Robots Measure Vitals to Minimize Interactions with COVID Patients Trend Watch: COVID-19 Forces Healthtech Innovations from Robots to Partnerships Researchers at Simon Fraser University in Canada have developed three different robots that can sense and measure patients’ healthcare parameters, inc...

    By PharmaVoice Team • April 1, 2021